{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "document_type": "article", "multimedia": [], "abstract": "CVS Health announces Gilead Sciences' hepatitis drugs Harvoni and Sovaldi will be exclusive option for its patients; move partly blunts drug plan between Express Scripts and AbbVie.", "type_of_material": "News", "word_count": "435", "lead_paragraph": "The agreement partly offsets a similar pact between the pharmacy benefit manager Express Scripts and AbbVie, another maker of a costly hepatitis C drug.", "pub_date": "2015-01-06T00:00:00Z", "_id": "54ab437838f0d83eda14cc77", "byline": {"contributor": "", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "source": "The New York Times", "snippet": "The agreement partly offsets a similar pact between the pharmacy benefit manager Express Scripts and AbbVie, another maker of a costly hepatitis C drug.", "web_url": "http://www.nytimes.com/2015/01/06/business/gilead-strikes-hepatitis-drug-deal-with-cvs-health.html", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "value": "CVS Caremark Corporation", "is_major": "Y", "name": "organizations"}, {"rank": "2", "value": "Gilead Sciences Inc", "is_major": "Y", "name": "organizations"}, {"rank": "3", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "name": "subject"}, {"rank": "4", "value": "Hepatitis", "is_major": "Y", "name": "subject"}, {"rank": "5", "value": "AbbVie Inc", "is_major": "Y", "name": "organizations"}, {"rank": "6", "value": "Express Scripts Inc", "is_major": "Y", "name": "organizations"}, {"rank": "7", "value": "Harvoni (Drug)", "is_major": "N", "name": "subject"}, {"rank": "8", "value": "Sovaldi (Drug)", "is_major": "N", "name": "subject"}], "headline": {"main": "Gilead Strikes Hepatitis Drug Deal With CVS Health", "print_headline": "CVS Gives Gilead Exclusivity for Two Hepatitis Drugs"}}